- Home
- ABT vs GS Comparison
ABT vs GS Comparison
Compare ABT & GS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABT
- GS
- Stock Information
- Founded
- ABT 1888
- GS 1869
- Country
- ABT United States
- GS United States
- Employees
- ABT N/A
- GS N/A
- Industry
- ABT Medical/Dental Instruments
- GS Investment Bankers/Brokers/Service
- Sector
- ABT Health Care
- GS Finance
- Exchange
- ABT Nasdaq
- GS Nasdaq
- Market Cap
- ABT 221.0B
- GS 187.7B
- IPO Year
- ABT N/A
- GS 1999
- Fundamental
- Price
- ABT $133.55
- GS $613.84
- Analyst Decision
- ABT Buy
- GS Buy
- Analyst Count
- ABT 18
- GS 15
- Target Price
- ABT $140.44
- GS $602.54
- AVG Volume (30 Days)
- ABT 6.1M
- GS 2.1M
- Earning Date
- ABT 07-17-2025
- GS 07-16-2025
- Dividend Yield
- ABT 1.77%
- GS 1.95%
- EPS Growth
- ABT 139.92
- GS 68.40
- EPS
- ABT 7.70
- GS 42.98
- Revenue
- ABT $42,344,000,000.00
- GS $53,044,000,000.00
- Revenue This Year
- ABT $7.53
- GS $9.36
- Revenue Next Year
- ABT $7.69
- GS $4.33
- P/E Ratio
- ABT $17.34
- GS $14.29
- Revenue Growth
- ABT 5.00
- GS 13.52
- 52 Week Low
- ABT $99.71
- GS $437.37
- 52 Week High
- ABT $141.23
- GS $672.19
- Technical
- Relative Strength Index (RSI)
- ABT 54.10
- GS 62.41
- Support Level
- ABT $132.19
- GS $592.90
- Resistance Level
- ABT $134.87
- GS $618.63
- Average True Range (ATR)
- ABT 1.98
- GS 12.67
- MACD
- ABT -0.04
- GS -1.84
- Stochastic Oscillator
- ABT 54.36
- GS 80.86
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 14% of its revenue comes from investment banking, 42% from trading, 20% from asset & wealth management, 15% from net interest income, and 9% from other principal transactions. Around 64% of the company's net revenue is generated in the Americas, 13% in Asia, and 23% in Europe, the Middle East, and Africa.